Molecular and cellular biology of endothelin and its receptors—part ii

Journal of Hypertension

Volumn 11, Issue 2, 1993, Pages 121-126

  Lüscher, Thomas F ^a   Oemar, Barry S ^a   Boulanger, Chantai M ^a   Hahn, Alfred W A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Atherosclerosis; Endothelins; Hypertension; Receptors; Signal transduction

Indexed keywords

CYCLO(DEXTRO GLUTAMYLALANYL DEXTRO ALLO ISOLEUCYLLEUCYL DEXTRO TRYPTOPHYL); CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN DERIVATIVE; ENDOTHELIN RECEPTOR ANTAGONIST; INDOMETACIN; RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ATHEROSCLEROSIS; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR BIOLOGY; NONHUMAN; RAT; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMAL; ARTERIOSCLEROSIS; ENDOTHELINS; HUMAN; HYPERTENSION; KIDNEY; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ENDOTHELIN; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T;

EID: 0027246238     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199302000-00002     Document Type: Article

References (86)

1. Lüscher TF, Oemar BS, Boulanger CM, Hahn AWA: Molecular and cellular biology of endothelin and its receptors—Part I. J Hypertens 1993, 11:7–11.
2. Marsden PA, Danthuluri NR, Brenner BM, Ballermann BJ, Brock TA: Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization. Biochem Biophys Res Commun 1989, 158:86–93.
3. Resink TJ, Scott-Burden T, Bühler FR: Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1988, 157:1360–1368.
4. + exchange, c-fos expression, and mitogenesis in rat mesengial cells. J Clin Invest 1989, 83:708–712.
5. Sugiura M, Inagami T, Hare GM, Johns JA: Endothelin action: inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun 1989, 158:170–176.
6. van Renterghem C, Vigne P, Barhanin J, Schmid AA, Frelin C, Lazdunski M: Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun 1988, 157:977–985.
7. Wallnöfer A, Weir S, Rliegg U, Cauvin C: The mechanism of action of endothelin-1 as compared with other agonists in vascular smooth muscle. J Cardiovasc Pharmacol 1989, 13 (suppl 5):23–31.
8. Miasiro N, Yamamoto H, Kanaide H, Nakamura M: Does endothelin mobilize calcium from intracellular store sites in rat aortic vascular smooth muscle cells in primary culture? Biochem Biophys Res Commun 1988, 156:312–317.
9. Yang Z, Bauer E, von Segesser L, Stulz P, Turina M, Lüscher TF: Different mobilization of calcium in endothelin-1-induced contractions in human arteries and veins: effects of calcium antagonists. J Cardiovasc Pharmacol 1990, 16:654–660.
10. 2+ channel in vascular smooth muscle. Proc Nati Acad Sci USA 1989, 86:3915–3918.
11. Kiowski W, Lüscher TF, Linder L, Bühler FR: Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991, 83:469–475.
12. Miller VM, Komori K, Burnett JJ, Vanhoutte PM: Differential sensitivity to endothelin in canine arteries and veins. Am J Physiol 1989, 257:H1127–H1131.
13. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al: A novel potent vasaoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411–415.
14. Lüscher TF, Yang Z, Tschudi M, von Segesser L, Stulz P, Boulanger CM, et al: Interaction between endothelin-1 and endothelin-derived relaxing factor in human arteries and veins. Circ Res 1990, 66:1088–1094.
15. Miller WL, Redfield MM, Burnett JJ: Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 1989, 83:317–320.
16. Brain SD, Crossman DC, Buckley TL, Williams TJ; Endothelin-1: demonstration of potent effects on the microcirculation of humans and other species. J Cardiovasc Pharmacol 1989, 13 (suppl 5):147–149.
17. 2+ antagonists. J Cardiovasc Pharmacol 1989, 13 (suppl 5):218–219.
18. Clarke JG, Larkin SW, Benjamin N, Keogh BE, Chester A, Davies GJ, et al: Endothelin-1 is a potent long-lasting vasoconstrictor in dog peripheral vasculature in vivo. J Cardiovasc Pharmacol 1989, 13 (suppl 5):211–212.
19. D’Orleans JP, Finet M, de Nucci G, Vane JR: Pharmacology of endothelin-1 in isolated vessels: effect of nicardip-ine, methylene blue, hemoglobin, and gossypol. J Cardiovasc Pharmacol 1989, 13 (suppl 5):19–22.
20. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley RJ: Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 1988, 255:R1064–R1068.
21. Walder CE, Thomas GR, Thiemermann C, Vane JR: The hemo-dynamic effects of endothelin-1 in the pithed rat. J Cardiovasc Pharmacol 1989, 13 (suppl 5):93–97.
22. Dohi Y, Lüscher TF: Endothelin in hypertensive resistance arteries. Intraluminal and extraluminal dysfunction. Hypertension 1991, 18:543–549.
23. Pohl U, Busse R: Differential vascular sensitivity to Iumi-nally and adventitially applied endothelin-1. J Cardiovasc Pharmacol 1989, 13 (suppl 5):188–190.
24. Yanagisawa M, Masaki T: Biochemistry and molecular biology of the endothelins. Trends Pharmacol Sci 1989, 10:374–378.
25. Saijonmaa O, Ristimäki A, Fyhrquist F: Atrial natriuretic pep-tide, nitroglycerine, and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun 1990, 173:514–520.
26. Martin ER, Brenner BM, Bailermann BJ: Heterogeneity of cell surface endothelin receptors. J Biol Chem 1990, 265:14044–14049.
27. Samson WK, Skala KD, Alexander BD, Huang FL: Pituitary site of action of endothelin: selective inhibition of pro-Iactin release in vitro. Biochem Biophys Res Commun 1990, 169:737–743.
28. Tabuchi Y, Nakamaru M, Rakugi H, Nagano M, Ogihara T: Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochem Biophys Res Commun 1989, 159:1304–1308.
29. Godfraind T, Mennig D, Morel N, Wibo M: Effect of endothelin-1 on calcium channel gating by agonists in vascular smooth muscle. J Cardiovasc Pharmacol 1989, 13 (suppl 5):112–117.
30. Yang ZH, Richard V, von Segesser L, Bauer E, Stulz P, Turina M, et al: Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation 1990, 82:188–195.
31. Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, et al: Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991, 69:209–215.
32. Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembatski CC, Brown JH, et al: Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly and cardiac gene expression in ventricular myocytes. J Biol Chem 1990, 265:20555–20562.
33. Hahn AWA, Resink TJ, Kern F, Bühler FR: Effects of endothelin-1 on vascular smooth muscle cell phenotypic differentiation. J Cardiovasc Pharmacol 1992 20 (suppl 12):33–36.
34. Dubin D, Pratt RE, Cooke JP, Dzau VJ: Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1989, 1:13–16.
35. Warner TD, de Nucci G, Vane JR: Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 1989, 159:325–326.
36. Wright CE, Fozard JR: Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats. Eur J Pharmacol 1988, 155:201–203.
37. Thiemermann C, Lidbury PS, Thomas GR, Vane JR: Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit. J Cardiovasc Pharmacol 1989, 13 (suppl 5):138–141.
38. De Nuca G, Thomas R, D’Orleans JP, Antones E, Walder C, Warner TD, et al: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988, 85:9797–9800.
39. Resink TJ, Scott-Burden T, Bühler FR: Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1989, 158:279–286.
40. Ihara M, Fukuroda T, Saeki T, Nlshikibe M, Kojiri K, Suda H, et al: An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis. Biochem Biophys Res Commun 1991, 178:132–137.
41. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, et al.: Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 1992, 50:247–255.
42. Nakamichi K, Ihara M, Kobayashi M, Saeki T, Ishikawa K, Yano M: Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Alal, 3, 11, 15]ET-1. Biochem Biophys Res Commun 1992, 182:144–150.
43. Saeki T, Ihara M, Fukuroda T, Yamagiwa M, Yano M: [Alal, 3, 11, 15]endothelin-1 analogs with ETB agonistic activity. Biochem Biophys Res Commun 1991, 179:286–292.
44. Lüscher TF, Bock AH, Yang Z, Diederich D: Endothelium-derived relaxing and contracting factors: perspectives in nephrology. Kidney Int 1991, 39:575–590.
45. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest 1989, 83:336–342.
46. Firth JD, Ratcliffe PJ, Raine AE, Ledingham JG: Endothelin: an important factor in acute renal failure? Lancet 1988, ii:1179–1182.
47. Kitamura K, Tanaka T, Rato J, Ogawa T, Eto T, Tanara K: Immunoreactive endothelin in rat kidney inner medulla: marked decrease in spontaneously hypertensive rats. Biochem Biophys Res Commun 1989, 162:38–44.
48. King AJ, Brenner BM, Anderson S: Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989, 256:F1051–F1058.
49. +. ATPase in intact renaltubular epithelial cells. Am J Physiol 1989, 257.C1101–C1107.
50. Kon V, Yoshioka T, Fogo A, Ichikawa I: Glomerular actions of endothelin in vivo. J Clin Invest 1989, 83:1762–1767.
51. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990, 348:732–735.
52. Suzuki N, Miyauchi T, Tomobe Y, Matsumoto H, Goto K, Masaki T, et al: Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun 1990, 167:941–947.
53. Miyauchi T, Yanagisawa M, Suzuki N, Iida K, Sugishita Y, Fujino M, et al: Venous plasma concentrations of endothelin in normal and hypertensive subjects [abstract]. Circulation 1989, 80 (suppl II):112-280.
54. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, et al: A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990, 78:261–264.
55. Schiffrin EL, Thibault G: Plasma endothelin in human essential hypertension. Am J Hypertens 1991, 4:303–308.
56. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, et al: Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990, 15:493–496.
57. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, et al: Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990, 88:614–618.
58. Saito Y, Nakao K, Mukoyama M, Shirakami G, Itoh H, Yamada T, et al: Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension 1990, 15:734–738.
59. Koyama H, Tabata T, Nishzawa Y, Inoue T, Morii H, Yamaji T: Plasma endothelin levels in patients with uraemia. Lancet 1989, i:991–992.
60. Cernacek P, Stewart DJ: Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 1989, 161:562–567.
61. Emori T, Hirata Y, Aizawa T, Ando T, Ando K, Shichiri M, et al: Plasma endothelin levels in patients with coronary artery disease undergoing percutaneous coronary angio-plasty. Circulation 1989, 80 (suppl II):II2327.
62. Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, et al: Circulating immunoreactive endothelin in ischaemic heart disease. Am Heart J 1990, 119:801–806.
63. Cavero PG, Miller WL, Heublein DM, Marguues KB, Burnett JCJ: Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol 1990, 259:F312–F317.
64. Tomita U, Ujie K, Nakanishi T, Tomura S, Matsuda O, Ando K, et al: Plasma endothelin levels in patients with acute renal failure [letter]. N Engl J Med 1990, 321:1127.
65. Miyauchi T, Ishikawa T, Tomobe Y, Yanagisawa M, Kimura S, Sugishita Y, et al: Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 1989, 14:427–434.
66. Diederich D, Yang Z, Bühler FR, Lüscher TP: Edothelium-derived relaxing factor and endothelin in resistance arteries of hypertensive rats [abstract]. J Vasc Med Biol 1989, 1 (3):167.
67. Tomobe Y, Mlyauchi T, Saito A, Yanagisawa M, Klmura S, Goto K, et al: Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats. Eur J Pharmacol 1988, 152:373–374.
68. Criscione L, Nellis P, Riniker B, Thomann H, Bürdet R: Reactivity and sensitivity of mesenteric vascular beds and aortic rings of spontaneously hypertensive rats to endothelin: effects of calcium entry blockers. Br J Pharmacol 1990, 100:31–36.
69. Ishikawa T, Tomobe Y, Yanagisawa M, Klmura S, Masaki T, Goto K: Increased sensitivity to endothelin-1 in spontaneously hypertensive rats is closely related to resting membrane potential [abstract]. J Am Coll Cardiol 1990, 15:67A.
70. Rossi G, Cargnelli G, Bova S, Pessina AC: Aging and vascular responsiveness to endothelin (ET) in SHR and WKY [abstract]. J Am Coll Cardiol 1990, 15:67A
71. Dohi Y, Criscione L, Lüscher TF: Renovascular hypertension impairs formation of endothelium-derived relaxing factors and sensitivity to endothelin-1 in resistance arteries. Br J Pharmacol 1991, 104:349–354.
72. 125I-endothelin-1 binding to brain and cardiac membranes from normoten-sive and spontaneously hypertensive rats. Eur J Pharmacol 1990, 177:205–209.
73. Clozel M: Endothelin sensitivity and receptor binding in the aorta of spontaneously hypertensive rats. J Hypertens 1989, 7:913–917.
74. Resink TJ, Scott-Burden T, Weber E, Bühler FR: Characteristic cellular response to endothelin-1 in vascular smooth muscle cells from normotensive Wistar-Kyoto and spontaneously hypertensive rats. J Vasc Med Biol 1990, 2:116–124.
75. Winquist RJ, Scott AL, Vlasuk GP: Enhanced release of atrial natriuretic factor by endothelin in atria from hypertensive rats. Hypertension 1989, 14:111–114.
76. Dohi Y, Lüscher TF: Aging differentially affects direct and indirect actions of endothelin-1 in perfused mesenteric arteries of the rat. Br J Pharmacol 1990, 100:889–893.
77. Dohi Y, Hahn AWA, Boulanger CM, Bühler FR, Lüscher TF: Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992, 19:131–137.
78. Yano M, Okada K, Takada J, Hioki Y, Matsuyama K, Fukuroda T, et al: Endothelin converting enzyme and its in vitro and in vivo inhibition. J Cardiovasc Pharmacol 1991, 17 (suppl 7):29–33.
79. Boulanger CM, Tanner FC, Bèa M, Hahn AWA, Werner A, Lüscher TF: Oxidized low-density lipoproteins induce mRNA expression and release of endothelin from the human and porcine endothelium. Circ Res 1992, 70:1191–1197.
80. Yiä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, et al: Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989, 84:1086–1095.
81. Arendt RM, Wilbert-Lamper U, Heucke L: Increased plasma endothelin in patients with hyperlipoproteinemia and stable or unstable angina [abstract]. Circulation 1990, 82 (suppl III):III248.
82. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JCJ: Circulating and tissue endothelin immuno-reactivity in advanced atherosclerosis. N Engl J Med 1991, 325:997–1001.
83. Boulanger C, Lüscher TF: Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990, 85:587–590.
84. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, et al: Release of immunoreactive endothelin from porcine aortic strips. Hypertension 1990, 15:718–723.
85. Hahn AWA, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Bühler FR: Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regulation 1990, 1:649–659.
86. Resink TJ, Hahn AW, Scott-Burden T, Powell J, Weber E, Bühler FR: Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun 1990, 168:1303–1310.